Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTCT | CGON | SRRK | ||
| Company | Ptc Therapeutics | Cg Oncology Inc | Scholar Rock Holding Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 67.89 | 69.10 | 46.48 | ||
| High | 71.08 | 70.29 | 47.11 | ||
| Low | 67.89 | 66.56 | 45.72 | ||
| Latest | 69.22 | 66.82 | 46.29 | ||
| Change | +0.99 | -1.86 | -0.19 | ||
| % Change | +1.45% | -2.71% | -0.41% | ||
| Volume | 1,058,552 | 757,935 | 1,268,192 | ||
| 20-Day Average Volume | 855,933 | 1,190,432 | 1,657,180 | ||
| Previous Close | 68.23 | 68.68 | 46.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 70.03 | 68.42 | 48.56 | ||
| 20-Day Raw Stochastic | 51.49% | 35.99% | 43.54% | ||
| 20-Day Relative Strength | 49.37 | 52.22 | 48.42 | ||
| Weighted Alpha | +33.30 | +119.68 | +41.35 | ||
| Today's Opinion | 8% Buy | 80% Buy | 88% Buy | ||
| Previous Opinion | 8% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 8% Sell | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.29% since 04/20/26 | -5.09% since 04/20/26 | -3.16% since 04/20/26 | ||
| Low | 67.42 on 04/24/26 | 66.56 on 04/27/26 | 45.72 on 04/27/26 | ||
| High | 72.33 on 04/21/26 | 73.00 on 04/22/26 | 48.83 on 04/22/26 | ||
| 1-Month | |||||
| %Chg | +4.67% since 03/27/26 | +3.40% since 03/27/26 | +8.66% since 03/27/26 | ||
| Low | 64.37 on 03/30/26 | 63.03 on 04/16/26 | 42.17 on 03/30/26 | ||
| High | 73.79 on 04/14/26 | 73.56 on 04/17/26 | 51.63 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | -8.31% since 01/27/26 | +21.27% since 01/27/26 | +5.23% since 01/27/26 | ||
| Low | 61.43 on 03/06/26 | 48.51 on 02/05/26 | 38.75 on 03/19/26 | ||
| High | 78.38 on 01/28/26 | 73.56 on 04/17/26 | 51.63 on 04/08/26 | ||
| 6-Month | |||||
| %Chg | +3.19% since 10/27/25 | +50.87% since 10/27/25 | +51.77% since 10/27/25 | ||
| Low | 61.43 on 03/06/26 | 35.80 on 11/11/25 | 27.07 on 11/07/25 | ||
| High | 87.50 on 11/26/25 | 73.56 on 04/17/26 | 51.63 on 04/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,657,086 | 5,798,995 | 5,545,157 | ||
| Shares Outstanding, K | 82,912 | 84,435 | 119,302 | ||
| Annual Sales | 1,730,660,000 | 4,040,000 | 0 | ||
| Annual Net Income | 682,640,000 | -161,000,000 | -377,940,000 | ||
| Last Quarter Sales | 164,680,000 | 2,320,000 | 0 | ||
| Last Quarter Net Income | -134,970,000 | -41,310,000 | -90,960,000 | ||
| 60-Month Beta | 0.55 | 0.70 | 0.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.67 on 02/19/26 | -0.51 on 02/27/26 | -0.88 on 03/03/26 | ||
| Earnings Date | 05/07/26 | 05/12/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 8.86 | 0.00 | 0.00 | ||